Written in Blood

Written in Blood

Research from recent issues of Blood

WIB_icon

Asciminib Superior to Bosutinib in Chronic-Phase CML

Asciminib was more effective than bosutinib at improving the rate of a major molecular response in patients with chronic myeloid leukemia in chronic phase...
WIB_icon

Flow Cytometry as a Prognostic Tool for Children With Down Syndrome and AML

The use of flow cytometry alone to determine measurable residual disease (MRD) status did not sufficiently identify children with acute myeloid leukemia (AML) and...
WIB_icon

Blunted Response to COVID-19 Vaccines in Transplant and Cellular Therapy Recipients

Many patients who undergo bone marrow transplant and CAR-T cell therapy do not mount a detectable humoral response to authorized COVID-19 vaccines, according to...
WIB_icon

Belumosudil Induces Responses in Refractory Chronic Graft-Versus-Host Disease

Belumosudil, a selective Rho-associated coiled-coil–containing protein kinase-2 (ROCK2) inhibitor, was associated with organ responses in heavily pretreated patients with chronic graft-versus-host disease (cGVHD) that...
WIB_icon

Danicopan Improves Hemoglobin, Reduces Transfusion Requirements in Eculizumab-Treated Patients With PNH

First-in-class oral factor D inhibitor danicopan improved hemoglobin (Hb) and reduced transfusion requirements in transfusion-dependent patients with paroxysmal nocturnal hemoglobinuria (PNH) who had previously...
WIB_icon

Omidubicel Improves Outcomes, Reduces Hospital Stay for Patients with Hematologic Malignancies

Patients with hematologic malignancies who received umbilical cord blood transplantation with omidubicel engrafted faster, had fewer infections, and spent less time in the hospital, compared...
WIB_icon

Gene Therapy Shows Durable Efficacy in Young Patients With ADA Severe Combined Immune Deficiency

Recent results published in Blood suggest gene therapy could offer an alternative to transplant for young patients with adenosine deaminase (ADA) severe combined immune...
WIB_icon

Survival Outcomes After HLA-Haploidentical Relative Versus Matched Unrelated Donor Transplant in Acute Leukemias and...

In patients with acute leukemias or myelodysplastic syndromes (MDS), those who underwent haploidentical relative hematopoietic cell transplantation (haploHCT) had higher rates of grade 3-4...
WIB_icon

Less-Intensive Therapies Increase Mortality Risk, But Decrease Hospital Stay, in Older Patients With AML

Although the use of less-intensive therapies is associated with an increased risk of mortality in older patients with acute myeloid leukemia (AML), patients treated...
WIB_icon

Is Gene Therapy Cost-Effective for Hemophilia B?

A study published in Blood found the use of gene therapy for hemophilia B to be more cost-effective than prophylaxis or on-demand treatment with...
Advertisement

Current Issue

September 2021 Volume 7 Issue 11

This issue discusses fertility preservation for young patients with cancer, reviews treatment options for primary immune thrombocytopenia, and more.

Block title